Annual Accounts Payable
$206.30 K
-$802.00 K-79.54%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual accounts payable is $206.30 thousand, with the most recent change of -$802.00 thousand (-79.54%) on December 1, 2023.
- During the last 3 years, KPRX annual accounts payable has fallen by -$228.50 thousand (-52.55%).
- KPRX annual accounts payable is now -85.39% below its all-time high of $1.41 million, reached on December 31, 2016.
Performance
KPRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$660.40 K
+$391.80 K+145.87%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly accounts payable is $660.40 thousand, with the most recent change of +$391.80 thousand (+145.87%) on September 1, 2024.
- Over the past year, KPRX quarterly accounts payable has increased by +$535.00 thousand (+426.63%).
- KPRX quarterly accounts payable is now -53.23% below its all-time high of $1.41 million, reached on December 31, 2016.
Performance
KPRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KPRX Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -79.5% | +426.6% |
3 y3 years | -52.5% | +403.0% |
5 y5 years | +223.9% | +403.0% |
KPRX Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -79.5% | +28.5% | -34.5% | +426.6% |
5 y | 5-year | -79.5% | +28.5% | -34.5% | +1009.9% |
alltime | all time | -85.4% | +1405.8% | -53.2% | +8053.1% |
Kiora Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $660.40 K(+145.9%) |
Jun 2024 | - | $268.60 K(-16.9%) |
Mar 2024 | - | $323.10 K(+56.6%) |
Dec 2023 | $206.30 K(-79.5%) | $206.30 K(+64.5%) |
Sep 2023 | - | $125.40 K(-4.5%) |
Jun 2023 | - | $131.30 K(-77.7%) |
Mar 2023 | - | $587.50 K(-41.7%) |
Dec 2022 | $1.01 M(+527.8%) | $1.01 M(+34.6%) |
Sep 2022 | - | $749.20 K(-4.7%) |
Jun 2022 | - | $785.80 K(+159.9%) |
Mar 2022 | - | $302.30 K(+88.2%) |
Dec 2021 | $160.60 K(-63.1%) | $160.60 K(-62.2%) |
Sep 2021 | - | $424.90 K(+45.4%) |
Jun 2021 | - | $292.30 K(-36.1%) |
Mar 2021 | - | $457.30 K(+5.2%) |
Dec 2020 | $434.80 K(+106.8%) | $434.80 K(+630.8%) |
Sep 2020 | - | $59.50 K(-36.9%) |
Jun 2020 | - | $94.30 K(-40.3%) |
Mar 2020 | - | $158.00 K(-24.9%) |
Dec 2019 | $210.30 K | $210.30 K(-80.3%) |
Sep 2019 | - | $1.07 M(+1005.2%) |
Jun 2019 | - | $96.60 K(-60.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $244.20 K(+283.4%) |
Dec 2018 | $63.70 K(-91.0%) | $63.70 K(-80.4%) |
Sep 2018 | - | $324.20 K(-8.9%) |
Jun 2018 | - | $356.00 K(+60.4%) |
Mar 2018 | - | $221.90 K(-68.6%) |
Dec 2017 | $706.10 K(-50.0%) | $706.10 K(+7.2%) |
Sep 2017 | - | $658.60 K(-32.2%) |
Jun 2017 | - | $970.90 K(-25.9%) |
Mar 2017 | - | $1.31 M(-7.2%) |
Dec 2016 | $1.41 M(+238.1%) | $1.41 M(+0.6%) |
Sep 2016 | - | $1.40 M(+14.1%) |
Jun 2016 | - | $1.23 M(+41.5%) |
Mar 2016 | - | $869.30 K(+108.1%) |
Dec 2015 | $417.70 K(-26.2%) | $417.70 K(+164.2%) |
Sep 2015 | - | $158.10 K(-53.2%) |
Jun 2015 | - | $337.60 K(+18.0%) |
Mar 2015 | - | $286.20 K(-49.4%) |
Dec 2014 | $565.90 K(+4030.7%) | $565.90 K(+105.3%) |
Sep 2014 | - | $275.70 K(+20.1%) |
Jun 2014 | - | $229.60 K(+2734.6%) |
Mar 2014 | - | $8100.00(-40.9%) |
Dec 2013 | $13.70 K(-87.5%) | $13.70 K |
Dec 2012 | $109.70 K | - |
FAQ
- What is Kiora Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual accounts payable year-on-year change?
- What is Kiora Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly accounts payable year-on-year change?
What is Kiora Pharmaceuticals annual accounts payable?
The current annual accounts payable of KPRX is $206.30 K
What is the all time high annual accounts payable for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual accounts payable is $1.41 M
What is Kiora Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, KPRX annual accounts payable has changed by -$802.00 K (-79.54%)
What is Kiora Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of KPRX is $660.40 K
What is the all time high quarterly accounts payable for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly accounts payable is $1.41 M
What is Kiora Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, KPRX quarterly accounts payable has changed by +$535.00 K (+426.63%)